The peroxisome proliferator-activated receptor-γ 2 (PPAR-γ 2) Pro12Ala polymorphism is associated with decreased risk of advanced diabetic nephropathy in patients with type 2 diabetes mellitus (DM2)

被引：0
|
作者：
Caramori, ML
Canani, LH
Costa, L
Gross, JL
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A49 / A49
页数：1
相关论文
共 50 条
  • [21] No association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 with diabetic nephropathy in Japanese diabetic subjects
    Tamemoto, H
    Namai, K
    Saitoh, T
    Ishikawa, SE
    Kawakami, M
    DIABETES, 2005, 54 : A206 - A206
  • [22] Association of Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor gamma 2 (PPARγ2) Gene with Type 2 Diabetes Mellitus in Ethnic Kashmiri Population
    Misbah Majid
    Akbar Masood
    Showkat Ahmad Kadla
    Iqra Hameed
    Bashir A. Ganai
    Biochemical Genetics, 2017, 55 : 10 - 21
  • [23] Association of Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor gamma 2 (PPARγ2) Gene with Type 2 Diabetes Mellitus in Ethnic Kashmiri Population
    Majid, Misbah
    Masood, Akbar
    Kadla, Showkat Ahmad
    Hameed, Iqra
    Ganai, Bashir A.
    BIOCHEMICAL GENETICS, 2017, 55 (01) : 10 - 21
  • [24] Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2:: Association to type 2 diabetes and response to a glucose tolerance test in a risk population for diabetes
    Temelkova-Kurktschiev, T
    Hanefeld, M
    Koehler, C
    Henkel, E
    Leonhardt, W
    Pietzsch, J
    Laakso, M
    DIABETES, 2002, 51 : A269 - A269
  • [25] The peroxisome proliferator-activated receptor gamma (PPAR-γ2) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenarians
    Scacchi, Renato
    Pinto, Alessandro
    Gambina, Giuseppe
    Rosano, Aldo
    Corbo, Rosa Maria
    BRAIN RESEARCH, 2007, 1139 : 1 - 5
  • [26] A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-γ2 is associated with combined hyperlipidaemia in obesity
    Swarbrick, MM
    Chapman, CML
    McQuillan, BM
    Hung, J
    Thompson, PL
    Beilby, JP
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 144 (03) : 277 - 282
  • [27] An analysis of peroxisome proliferator-activated receptor gamma (PPAR-γ2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits
    Scacchi, R.
    Pinto, A.
    Rickards, O.
    Pacella, A.
    De Stefano, G. F.
    Cannella, C.
    Corbo, R. M.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2007, 17 (09) : 632 - 641
  • [28] Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk
    Wang, Wei
    Shao, Yan
    Tang, Shenhua
    Cheng, Xianyong
    Lian, Haifeng
    Qin, Chengyong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 4066 - 4072
  • [29] Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with Type 2 diabetes
    Ahn, YM
    Lee, BC
    Kim, SI
    Byun, SH
    Ahn, SY
    Doo, HK
    DIABETOLOGIA, 2004, 47 : A425 - A425
  • [30] Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 gene on rosiglitazone response in type 2 diabetes
    Kang, ES
    Park, SY
    Kim, HJ
    Kim, CS
    Ahn, CW
    Cha, BS
    Lim, SK
    Nam, CM
    Lee, HC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (02) : 202 - 208
12345